{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:17:21Z","timestamp":1774916241860,"version":"3.50.1"},"reference-count":74,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2003,2,1]],"date-time":"2003-02-01T00:00:00Z","timestamp":1044057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2003,2]]},"DOI":"10.1016\/s0002-9149(02)03270-8","type":"journal-article","created":{"date-parts":[[2003,3,4]],"date-time":"2003-03-04T12:20:43Z","timestamp":1046780443000},"page":"23-29","source":"Crossref","is-referenced-by-count":107,"special_numbering":"S","title":["Prevention of stroke and dementia with statins"],"prefix":"10.1016","volume":"91","author":[{"given":"Carl J","family":"Vaughan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S0002-9149(02)03270-8_BIB1","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1161\/01.STR.28.7.1507","article-title":"American Heart Association Prevention Conference IV","volume":"28","author":"Sacco","year":"1997","journal-title":"Stroke"},{"key":"10.1016\/S0002-9149(02)03270-8_BIB2","unstructured":"National Heart, Lung, and Blood Institute. Morbidity and Mortality: 2000 Chart Book. Bethesda, MD: National Center for Health Statistics; 2000"},{"key":"10.1016\/S0002-9149(02)03270-8_BIB3","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0733-8619(18)31185-X","article-title":"Current status of risk factors for stroke","volume":"1","author":"Wolf","year":"1983","journal-title":"Neurol Clin"},{"key":"10.1016\/S0002-9149(02)03270-8_BIB4","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1097\/00041433-199912000-00009","article-title":"Effects of statins on carotid disease and stroke","volume":"10","author":"Crouse","year":"1999","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/S0002-9149(02)03270-8_BIB5","doi-asserted-by":"crossref","first-page":"136","DOI":"10.7326\/0003-4819-119-2-199307150-00008","article-title":"Cholesterol reduction and the risk for stroke in men","volume":"119","author":"Atkins","year":"1993","journal-title":"Ann Intern Med"},{"key":"10.1016\/S0002-9149(02)03270-8_BIB6","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1161\/01.CIR.96.2.701","article-title":"American Heart Association Prevention Conference IV","volume":"96","author":"Helgason","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/S0002-9149(02)03270-8_BIB7","doi-asserted-by":"crossref","first-page":"914","DOI":"10.7326\/0003-4819-124-10-199605150-00009","article-title":"Cholesterol reduction","volume":"124","author":"Gaziano","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.1016\/S0002-9149(02)03270-8_BIB8","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1056\/NEJM198904063201405","article-title":"Serum cholesterol levels and six-year mortality from stroke in 350,977 men screened for the multiple risk factor intervention trial","volume":"320","author":"Iso","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/S0002-9149(02)03270-8_BIB9","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1016\/S0140-6736(95)92836-7","article-title":"Cholesterol, diastolic blood pressure, and stroke","volume":"346","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/S0002-9149(02)03270-8_BIB10","first-page":"1383","article-title":"Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease","volume":"344","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/S0002-9149(02)03270-8_BIB11","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1056\/NEJM199610033351401","article-title":"The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels","volume":"335","author":"Sacks","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/S0002-9149(02)03270-8_BIB12","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1056\/NEJM200008033430502","article-title":"Pravastatin therapy and the risk of stroke","volume":"343","author":"White","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/S0002-9149(02)03270-8_BIB13","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1161\/01.STR.28.5.946","article-title":"Stroke, statins, and cholesterol","volume":"28","author":"Blauw","year":"1997","journal-title":"Stroke"},{"key":"10.1016\/S0002-9149(02)03270-8_BIB14","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1001\/archinte.1997.00440330039004","article-title":"Reductase inhibitor monotherapy and stroke prevention","volume":"157","author":"Crouse","year":"1997","journal-title":"Arch Intern Med"},{"key":"10.1016\/S0002-9149(02)03270-8_BIB15","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1001\/jama.285.13.1711","article-title":"Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes","volume":"285","author":"Schwartz","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/S0002-9149(02)03270-8_BIB16","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1161\/01.CIR.0000031568.40630.1C","article-title":"Effects of atorvastatin on stroke in patients with unstable angina on non-Q-wave myocardial infarction:","volume":"106","author":"Waters","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/S0002-9149(02)03270-8_BIB17","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0140-6736(02)09327-3","article-title":"MRC\/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals","volume":"360","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/S0002-9149(02)03270-8_BIB18","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/343425a0","article-title":"Regulation of the mevalonate pathway","volume":"343","author":"Goldstein","year":"1990","journal-title":"Nature"},{"key":"10.1016\/S0002-9149(02)03270-8_BIB19","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1056\/NEJM199908123410707","article-title":"Drug treatment of lipid disorders","volume":"341","author":"Knopp","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/S0002-9149(02)03270-8_BIB20","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1126\/science.2116664","article-title":"The cellular functions of small GTP-binding proteins","volume":"249","author":"Hall","year":"1990","journal-title":"Science"},{"key":"10.1016\/S0002-9149(02)03270-8_BIB21","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1161\/01.CIR.97.12.1129","article-title":"Upregulation of endothelial nitric oxide synthase by HMG-CoA reductase inhibitors","volume":"97","author":"Laufs","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/S0002-9149(02)03270-8_BIB22","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1056\/NEJM199412013312202","article-title":"Atherosclerotic disease of the aortic arch and the risk of ischemic stroke","volume":"331","author":"Amarenco","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/S0002-9149(02)03270-8_BIB23","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0735-1097(97)00449-X","article-title":"Mobile aortic atheroma and systemic emboli","volume":"31","author":"Dressler","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S0002-9149(02)03270-8_BIB24","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1161\/01.CIR.90.4.1679","article-title":"Effect of lovastatin on early carotid atherosclerosis and cardiovascular events","volume":"90","author":"Furberg","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/S0002-9149(02)03270-8_BIB25","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0002-9149(99)80580-3","article-title":"Pravastatin, lipids, and atherosclerosis in the carotid arteries (PLAC-II)","volume":"75","author":"Crouse","year":"1995","journal-title":"Am J Cardiol"},{"key":"10.1016\/S0002-9149(02)03270-8_BIB26","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1016\/S0002-9149(98)00691-2","article-title":"Effects of pravastatin on thoracic aortic atherosclerosis in patients with heterozygous familial hypercholesterolemia","volume":"82","author":"Pitsavos","year":"1998","journal-title":"Am J Cardiol"},{"key":"10.1016\/S0002-9149(02)03270-8_BIB27","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1161\/01.STR.28.11.2315","article-title":"Vascular effects of statins in stroke","volume":"28","author":"Delanty","year":"1997","journal-title":"Stroke"},{"key":"10.1016\/S0002-9149(02)03270-8_BIB28","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1056\/NEJM199011083231901","article-title":"Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B","volume":"323","author":"Brown","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/S0002-9149(02)03270-8_BIB29","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0140-6736(94)92082-6","article-title":"Effect of simvastatin on coronary atheroma: the Multicentre Anti-Atheroma Study (MAAS)","volume":"344","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/S0002-9149(02)03270-8_BIB30","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1161\/01.CIR.89.3.959","article-title":"Effects of monotherapy with an HMG-CoA reductase inhibitor on the progression of coronary atherosclerosis as assessed by serial quantitative arteriography. The Canadian Coronary Atherosclerosis Intervention Trial","volume":"89","author":"Waters","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/S0002-9149(02)03270-8_BIB31","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/S0140-6736(96)05190-2","article-title":"Statins do more than just lower cholesterol","volume":"348","author":"Vaughan","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/S0002-9149(02)03270-8_BIB32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0735-1097(99)00525-2","article-title":"The evolving role of statins in the management of atherosclerosis","volume":"35","author":"Vaughan","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S0002-9149(02)03270-8_BIB33","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S0741-5214(96)70237-9","article-title":"Atherosclerotic plaque rupture in symptomatic carotid artery stenosis","volume":"23","author":"Carr","year":"1996","journal-title":"J Vasc Surg"},{"key":"10.1016\/S0002-9149(02)03270-8_BIB34","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1161\/01.ATV.17.8.1521","article-title":"Effects of fluvastatin on leukocyte-endothelial cell adhesion in hypercholesterolemic rats","volume":"17","author":"Kimura","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/S0002-9149(02)03270-8_BIB35","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1161\/01.ATV.13.7.1013","article-title":"Oxidized LDL-induced leukocyte\/endothelium interaction in vivo involves the receptor for platelet activating factor","volume":"13","author":"Lehr","year":"1993","journal-title":"Arterioscler Thromb"},{"key":"10.1016\/S0002-9149(02)03270-8_BIB36","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1016\/S0735-1097(97)00324-0","article-title":"HMG-CoA reductase inhibitors decrease CD11b expression and CD11b-dependent adhesion of monocytes to endothelium and reduce increased adhesiveness of monocytes isolated from patients with hypercholesterolemia","volume":"30","author":"Weber","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S0002-9149(02)03270-8_BIB37","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1161\/01.CIR.92.6.1393","article-title":"Interstitial collagenase (MMP-1) expression in human carotid atherosclerosis","volume":"92","author":"Nikkari","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/S0002-9149(02)03270-8_BIB38","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1161\/01.CIR.103.7.993","article-title":"Statins alter smooth muscle cell accumulation and collagen content in established atheroma of Watanabe heritable hyperlipidemic rabbits","volume":"103","author":"Fukumoto","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/S0002-9149(02)03270-8_BIB39","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1161\/01.ATV.18.11.1671","article-title":"HMG-CoA reductase inhibitors reduce MMP-9 secretion by macrophages","volume":"18","author":"Bellosta","year":"1998","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/S0002-9149(02)03270-8_BIB40","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1161\/01.ATV.17.2.265","article-title":"Vastatins inhibit tissue factor in cultured human macrophages","volume":"17","author":"Colli","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/S0002-9149(02)03270-8_BIB41","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1161\/01.CIR.103.7.926","article-title":"Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques","volume":"103","author":"Crisby","year":"2001","journal-title":"Circulation"},{"issue":"suppl 3","key":"10.1016\/S0002-9149(02)03270-8_BIB42","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1212\/WNL.51.3_Suppl_3.S9","article-title":"The role of platelets in ischemic stroke","volume":"51","author":"del Zoppo","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/S0002-9149(02)03270-8_BIB43","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1161\/01.ATV.15.2.247","article-title":"Inhibition of thromboxane biosynthesis and platelet function by simvastatin in type IIa hypercholesterolemia","volume":"15","author":"Notarbartolo","year":"1995","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/S0002-9149(02)03270-8_BIB44","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1007\/BF01696223","article-title":"Effects of long-term treatment with lovastatin on the clotting system and blood platelets","volume":"64","author":"Mayer","year":"1992","journal-title":"Ann Hematol"},{"key":"10.1016\/S0002-9149(02)03270-8_BIB45","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1161\/01.ATV.15.6.759","article-title":"Platelet cytosolic Ca2+ and membrane dynamics in patients with primary hypercholesterolemia","volume":"15","author":"Le Quan Sang","year":"1995","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/S0002-9149(02)03270-8_BIB46","doi-asserted-by":"crossref","first-page":"3172","DOI":"10.1161\/01.CIR.92.11.3172","article-title":"Hyperlipidemia and coronary disease","volume":"92","author":"Lacoste","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/S0002-9149(02)03270-8_BIB47","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/00004872-199401000-00009","article-title":"Influence of cholesterol lowering on plasma membrane lipids and cationic transport systems","volume":"12","author":"Lijnen","year":"1994","journal-title":"J Hypertens"},{"key":"10.1016\/S0002-9149(02)03270-8_BIB48","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1161\/01.CIR.95.6.1370","article-title":"Low-density lipoproteins inhibit the Na+\/H+ antiport in human platelets","volume":"95","author":"Nofer","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/S0002-9149(02)03270-8_BIB49","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/ajh.2830440208","article-title":"Elevated plasma levels of vascular endothelial cell markers in patients with hypercholesterolemia","volume":"44","author":"Wada","year":"1993","journal-title":"Am J Hematol"},{"key":"10.1016\/S0002-9149(02)03270-8_BIB50","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0735-1097(97)00129-0","article-title":"Platelet-dependent thrombin generation in patients with hyperlipidemia","volume":"30","author":"Aoki","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S0002-9149(02)03270-8_BIB51","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1074\/jbc.270.1.319","article-title":"Oxidized low-density lipoprotein decreases the expression of endothelial nitric oxide synthase","volume":"270","author":"Liao","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1016\/S0002-9149(02)03270-8_BIB52","doi-asserted-by":"crossref","first-page":"8880","DOI":"10.1073\/pnas.95.15.8880","article-title":"Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase","volume":"95","author":"Endres","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/S0002-9149(02)03270-8_BIB53","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1161\/01.STR.31.10.2442","article-title":"Atorvastatin upregulates type III nitric oxide synthase in thrombocytes, decreases platelet activation, and protects from cerebral ischemia in normocholesterolemic mice","volume":"31","author":"Laufs","year":"2000","journal-title":"Stroke"},{"key":"10.1016\/S0002-9149(02)03270-8_BIB54","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1172\/JCI9639","article-title":"Neuroprotection mediated by changes in the endothelial actin cytoskeleton","volume":"106","author":"Laufs","year":"2000","journal-title":"J Clin Invest"},{"key":"10.1016\/S0002-9149(02)03270-8_BIB55","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1038\/79510","article-title":"The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals","volume":"6","author":"Kureishi","year":"2000","journal-title":"Nat Med"},{"key":"10.1016\/S0002-9149(02)03270-8_BIB56","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/21224","article-title":"Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation","volume":"399","author":"Dimmeler","year":"1999","journal-title":"Nature"},{"key":"10.1016\/S0002-9149(02)03270-8_BIB57","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1038\/82219","article-title":"Statins as a newly recognized type of immunomodulator","volume":"6","author":"Kwak","year":"2000","journal-title":"Nat Med"},{"key":"10.1016\/S0002-9149(02)03270-8_BIB58","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1084\/jem.160.2.618","article-title":"Interleukin 1 (IL-1) induces biosynthesis and cell surface expression of procoagulant activity in human vascular endothelial cells","volume":"160","author":"Bevilacqua","year":"1984","journal-title":"J Exp Med"},{"key":"10.1016\/S0002-9149(02)03270-8_BIB59","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1161\/01.STR.24.11.1746","article-title":"Interleukin-1 beta mRNA expression in ischemic rat cortex","volume":"24","author":"Liu","year":"1993","journal-title":"Stroke"},{"key":"10.1016\/S0002-9149(02)03270-8_BIB60","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1161\/01.STR.25.4.869","article-title":"Postischemic administration of an anti-Mac-1 antibody reduces ischemic cell damage after transient middle cerebral artery occlusion in rats","volume":"25","author":"Chopp","year":"1994","journal-title":"Stroke"},{"key":"10.1016\/S0002-9149(02)03270-8_BIB61","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1172\/JCI119812","article-title":"Lovastatin and phenylacetate inhibit the induction of nitric oxide synthase and cytokines in rat primary astrocytes, microglia, and macrophages","volume":"100","author":"Pahan","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/S0002-9149(02)03270-8_BIB62","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1161\/01.STR.30.9.1969","article-title":"Neuroprotective properties of statins in cerebral ischemia and stroke","volume":"30","author":"Vaughan","year":"1999","journal-title":"Stroke"},{"key":"10.1016\/S0002-9149(02)03270-8_BIB63","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/89058","article-title":"Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site","volume":"7","author":"Weitz-Schmidt","year":"2001","journal-title":"Nat Med"},{"key":"10.1016\/S0002-9149(02)03270-8_BIB64","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1126\/science.8346443","article-title":"Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer\u2019s disease in late onset families","volume":"261","author":"Corder","year":"1993","journal-title":"Science"},{"key":"10.1016\/S0002-9149(02)03270-8_BIB65","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0140-6736(96)09328-2","article-title":"Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer\u2019s disease in the Rotterdam Study","volume":"349","author":"Hofman","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/S0002-9149(02)03270-8_BIB66","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/ng1197-263","article-title":"Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition","volume":"17","author":"Bales","year":"1997","journal-title":"Nat Genet"},{"key":"10.1016\/S0002-9149(02)03270-8_BIB67","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1159\/000026149","article-title":"Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer\u2019s disease","volume":"17","author":"Notkola","year":"1998","journal-title":"Neuroepidemiology"},{"key":"10.1016\/S0002-9149(02)03270-8_BIB68","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1212\/WNL.45.6.1092","article-title":"Interactions of apolipoprotein E genotype, total cholesterol level, age, and sex in prediction of Alzheimer\u2019s disease","volume":"45","author":"Jarvik","year":"1995","journal-title":"Neurology"},{"key":"10.1016\/S0002-9149(02)03270-8_BIB69","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1001\/archneur.57.10.1439","article-title":"Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors","volume":"57","author":"Wolozin","year":"2000","journal-title":"Arch Neurol"},{"key":"10.1016\/S0002-9149(02)03270-8_BIB70","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/S0140-6736(00)03155-X","article-title":"Statins and the risk of dementia","volume":"356","author":"Jick","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/S0002-9149(02)03270-8_BIB71","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/S0002-9149(99)00533-0","article-title":"The design of a prospective study of Pravastatin in the Elderly at Risk (PROSPER). PROSPER Study Group. PROspective Study of Pravastatin in the Elderly at Risk","volume":"84","author":"Shepherd","year":"1999","journal-title":"Am J Cardiol"},{"key":"10.1016\/S0002-9149(02)03270-8_BIB72","doi-asserted-by":"crossref","first-page":"5856","DOI":"10.1073\/pnas.081620098","article-title":"Simvastatin strongly reduces levels of Alzheimer\u2019s disease beta-amyloid peptides Abeta 42 and Abeta 40 in vitro and in vivo","volume":"98","author":"Fassbender","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/S0002-9149(02)03270-8_BIB73","doi-asserted-by":"crossref","first-page":"5815","DOI":"10.1073\/pnas.081612998","article-title":"Low cholesterol stimulates the nonamyloidogenic pathway by its effect on the alpha-secretase ADAM 10","volume":"98","author":"Kojro","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/S0002-9149(02)03270-8_BIB74","doi-asserted-by":"crossref","first-page":"5371","DOI":"10.1073\/pnas.101123198","article-title":"A fluid connection","volume":"98","author":"Wolozin","year":"2001","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914902032708?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914902032708?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,3,17]],"date-time":"2020-03-17T15:47:54Z","timestamp":1584460074000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914902032708"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,2]]},"references-count":74,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2003,2]]}},"alternative-id":["S0002914902032708"],"URL":"https:\/\/doi.org\/10.1016\/s0002-9149(02)03270-8","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2003,2]]}}}